We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Reza Dana

Reza Dana MD, MPH, MSc

Director of the Cornea Service at Massachusetts Eye and Ear, Co-Director of the Harvard Medical School Cornea Center of Excellence, Harvard University, Boston, Massachusetts

Dr. Dana holds the Claes Dohlman Chair in Ophthalmology at Harvard Medical School.  He is Director of the Cornea Service at Massachusetts Eye and Ear, Co-Director of the Harvard Medical School Cornea Center of Excellence, Senior Scientist at the Schepens Eye Research Institute, and a member of the Harvard Medical School Committee on Immunology. A graduate of Johns Hopkins and Harvard Universities, he studies the molecular and cellular regulation of corneal and ocular surface immunity.

Disclosures

Dr. Dana is a consultant for Eleven Biotherapeutics (Cambridge, Massachusetts), Alcon (Fort Worth, Texas), Allergan (Irvine, California), Bausch & Lomb (Bridgewater, New Jersey), and Genentech (San Francisco, California). He also holds equity at Eleven Biotherapeutics (Cambridge, Massachusetts).